Cargando…
Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses
Monoclonal antibody technology has undergone rapid and innovative reinvention over the last 30 years. Application of these technologies to human samples revealed valuable therapeutic and experimental insights. These technologies, each with their own benefits and flaws, have proven indispensable for...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155207/ https://www.ncbi.nlm.nih.gov/pubmed/21876728 http://dx.doi.org/10.3410/B3-17 |
_version_ | 1782210092914966528 |
---|---|
author | Sullivan, Meghan Kaur, Kaval Pauli, Noel Wilson, Patrick C. |
author_facet | Sullivan, Meghan Kaur, Kaval Pauli, Noel Wilson, Patrick C. |
author_sort | Sullivan, Meghan |
collection | PubMed |
description | Monoclonal antibody technology has undergone rapid and innovative reinvention over the last 30 years. Application of these technologies to human samples revealed valuable therapeutic and experimental insights. These technologies, each with their own benefits and flaws, have proven indispensable for immunological research and in our fight to provide new treatments and improved vaccines for infectious disease. |
format | Online Article Text |
id | pubmed-3155207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Faculty of 1000 Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-31552072011-08-29 Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses Sullivan, Meghan Kaur, Kaval Pauli, Noel Wilson, Patrick C. F1000 Biol Rep Review Article Monoclonal antibody technology has undergone rapid and innovative reinvention over the last 30 years. Application of these technologies to human samples revealed valuable therapeutic and experimental insights. These technologies, each with their own benefits and flaws, have proven indispensable for immunological research and in our fight to provide new treatments and improved vaccines for infectious disease. Faculty of 1000 Ltd 2011-08-01 /pmc/articles/PMC3155207/ /pubmed/21876728 http://dx.doi.org/10.3410/B3-17 Text en © 2011 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes |
spellingShingle | Review Article Sullivan, Meghan Kaur, Kaval Pauli, Noel Wilson, Patrick C. Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses |
title | Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses |
title_full | Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses |
title_fullStr | Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses |
title_full_unstemmed | Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses |
title_short | Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses |
title_sort | harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155207/ https://www.ncbi.nlm.nih.gov/pubmed/21876728 http://dx.doi.org/10.3410/B3-17 |
work_keys_str_mv | AT sullivanmeghan harnessingtheimmunesystemsarsenalproducinghumanmonoclonalantibodiesfortherapeuticsandinvestigatingimmuneresponses AT kaurkaval harnessingtheimmunesystemsarsenalproducinghumanmonoclonalantibodiesfortherapeuticsandinvestigatingimmuneresponses AT paulinoel harnessingtheimmunesystemsarsenalproducinghumanmonoclonalantibodiesfortherapeuticsandinvestigatingimmuneresponses AT wilsonpatrickc harnessingtheimmunesystemsarsenalproducinghumanmonoclonalantibodiesfortherapeuticsandinvestigatingimmuneresponses |